Cryo-Cell International (FRA:ZCY) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:ZCY Cryo-Cell International Inc FRA:ZCY
66 GF Score
Price €3.42
GF Value €4.03
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Cryo-Cell International Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cryo-Cell International  (FRA:ZCY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Cryo-Cell International Cyclically Adjusted PS Ratio Related Terms


Cryo-Cell International Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Cyclically Adjusted PS Ratio Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 1.41 1.51 2.23 0.85

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 0.99 0.85 0.70 0.73

FRA:ZCY vs PIII, EHSI, DCGO: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Cyclically Adjusted PS Ratio falls into.


FRA:ZCY
66GF Score
Cryo-Cell International Inc FRA:ZCY
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Cryo-Cell International's Cyclically Adjusted Revenue per Share for the quarter that ended in May. 2026 is calculated as:

For example, Cryo-Cell International's adjusted Revenue per Share data for the three months ended in May. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of May. 2026 (Change)*Current CPI (May. 2026)
=0.829/335.1230*335.1230
=0.829

Current CPI (May. 2026) = 335.1230.

Cryo-Cell International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201608 0.748 240.849 1.041
201611 0.786 241.353 1.091
201702 0.732 243.603 1.007
201705 0.745 244.733 1.020
201708 0.768 245.519 1.048
201711 0.727 246.669 0.988
201802 0.724 248.991 0.974
201805 0.680 251.588 0.906
201808 0.808 252.146 1.074
201811 0.958 252.038 1.274
201902 0.782 252.776 1.037
201905 0.859 256.092 1.124
201908 0.869 256.558 1.135
201911 0.861 257.208 1.122
202002 0.849 258.678 1.100
202005 0.887 256.394 1.159
202008 0.862 259.918 1.111
202011 0.785 260.229 1.011
202102 0.690 263.014 0.879
202105 0.725 269.195 0.903
202108 0.726 273.567 0.889
202111 0.737 277.948 0.889
202202 0.733 283.716 0.866
202205 0.827 292.296 0.948
202208 0.888 296.171 1.005
202211 0.915 297.711 1.030
202302 0.865 300.840 0.964
202305 0.860 304.127 0.948
202308 0.863 307.026 0.942
202311 0.889 307.051 0.970
202402 0.868 310.326 0.937
202405 0.905 314.069 0.966
202408 0.907 314.796 0.966
202411 0.913 315.493 0.970
202502 0.933 319.082 0.980
202505 0.879 321.465 0.916
202508 0.835 323.976 0.864
202511 0.836 324.122 0.864
202602 0.812 326.785 0.833
202605 0.829 335.123 0.829

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €3.42 is trading 15.1% below its estimated GF Value™ of €4.03. GuruFocus considers Cryo-Cell International to be Modestly Undervalued.

Key valuation signals for FRA:ZCY:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €4.03 vs. price of €3.42 (15.1% below fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
66GF Score

Get the complete analysis for FRA:ZCY

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.42
Price
€4.03
GF Value